Wei, J., Meng, P., Terpstra, M. M., van Rijk, A., Tamminga, M., Scherpen, F., . . . van den Berg, A. (2021). Clinical Value of EGFR Copy Number Gain Determined by Amplicon-Based Targeted Next Generation Sequencing in Patients with EGFR-Mutated NSCLC. Target Oncol.
Styl cytowania ChicagoWei, Jiacong, et al. "Clinical Value of EGFR Copy Number Gain Determined By Amplicon-Based Targeted Next Generation Sequencing in Patients With EGFR-Mutated NSCLC." Target Oncol 2021.
Styl cytowania MLAWei, Jiacong, et al. "Clinical Value of EGFR Copy Number Gain Determined By Amplicon-Based Targeted Next Generation Sequencing in Patients With EGFR-Mutated NSCLC." Target Oncol 2021.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..